| PP1.01 |
Tjerk Aukema |
Clinical Cost Analysis between Transcutaneous and Percutaneous Bone Conduction Devices |
14:15 – 15:00 CET |
| PP1.02 |
Maria Åberg Håkansson |
Intra- and post-operative experiences from 51 surgeries of a new active transcutaneous bone-anchored implant system. |
14:15 – 15:00 CET |
| PP1.03 |
Sanja Spiric |
Important factors for the outcomes of cochlear implantation in children |
14:15 – 15:00 CET |
| PP1.04 |
Froukje Cals |
AC102 – Phase I Results and Phase II Initiation for a New Drug Candidate for the Treatment of Sudden Sensorineural Hearing Loss |
14:15 – 15:00 CET |
| PP1.05 |
Åsa Bonnard |
Long-term hearing results for otosclerosis patients receiving cochlear implants – Impact of facial nerve stimulation |
14:15 – 15:00 CET |
| PP1.06 |
Jona Minette Ligon |
Advancing Surgical Education and Skill Aquisition with the Exoscope for Cochlear Implantation in a Tertiary Hospital |
14:15 – 15:00 CET |
| PP1.07 |
Georg Schweizer |
Long-term Results of Reverse Fixation Clip Technique on Electrode Migration Rates in a Large Cochlear Implant Cohort |
14:15 – 15:00 CET |
| PP1.09 |
Emma Teunissen |
A prospective multicentre European study investigating a one-step drill system (MONO) for bone anchored hearing procedures – Experience and outcomes at 1 year. |
14:15 – 15:00 CET |
| PP1.10 |
Ahmad Saeed |
ATOH-1 Gene Therapy for Regenerating Hair Cells and Restoring Auditory Function in Mice with Acquired Sensorineural Hearing Loss: A Meta Analysis and Bioinformatic Analysis of Preclinical Studies |
14:15 – 15:00 CET |
| PP2.01 |
Zhengcai Lou |
Comparison of endoscopic cartilage myringoplasty with and without trimming perforation margins and epithelium of malleus handle for repairing subtotal perforation |
15:30 – 16:15 CET |
| PP2.02 |
Zhengcai Lou |
Comparison of long-term outcome of two endoscopic transtympanic myringoplasty for repairing large chronic perforations |
15:30 – 16:15 CET |
| PP2.03 |
Hedwig M Velde |
Exome variant prioritization in a large cohort of hearing-impaired individuals indicates IKZF2 to be associated with hearing loss and guides future research for unsolved cases |
15:30 – 16:15 CET |
| PP2.04 |
Jeremy Wales |
Progressive loss of sensitivity to electrical stimulation after cochlear implantation in X-linked POU3F4 incomplete partition 3 inner ear malformation deafness |
15:30 – 16:15 CET |
| PP2.05 |
Sekhar Bandyopadhyay |
NOTCHED CARTILAGE WITH INCUS INTERPOSITION OSSICULOPLASTY COMBINED WITH CAVITY OBLITERATION – A NOVEL APPROACH : STUDY OF 50 CASES. |
15:30 – 16:15 CET |
| PP2.06 |
Johan Frijns |
Neuroanatomical anomalies associated with the LAMM syndrome: Implications for ABI placement |
15:30 – 16:15 CET |
| PP2.07 |
Froukje Cals |
Postoperative surgical site infection in cholesteatoma surgery with and without mastoid obliteration, what can we learn? |
15:30 – 16:15 CET |
| PP2.08 |
Bob Lerut |
En Hamac tympanoplasty and canalplasty for optimal type 1 tympanoplasty outcomes |
15:30 – 16:15 CET |
| PP2.09 |
Kanu Saha |
External Auditory Canal Cholesteatoma: Clinical Presentation and Management of 22 cases |
15:30 – 16:15 CET |
| PP2.10 |
Chloe Swords |
Otopathology of Incomplete Partition Type III: Implications for Cochlear Implantation |
15:30 – 16:15 CET |
| PP2.11 |
Yibo Zhang |
A novel classification system and surgical strategies of first branchial cleft anomalies |
15:30 – 16:15 CET |
| PP3.01 |
Cuneyt M. Alper |
Success in Valsalva maneuver in each ear may vary in a patient due to differences in peri-luminal tissue pressures between the Eustachian tubes. |
16:15 – 17:00 CET |
| PP3.02 |
Raymond Van De Berg |
The vestibular implant: Results of the second generation device |
16:15 – 17:00 CET |
| PP3.03 |
Yu Si |
A Multicenter, Single-arm, Objective Performance Criteria-controlled Clinical Study of the Safety and Efficacy of the Double-lumen Eustachian Tube Balloon Catheter |
16:15 – 17:00 CET |
| PP3.04 |
Yu Si |
Targeted temporal bone CT guidance for intratympanic steroid therapy |
16:15 – 17:00 CET |
| PP3.05 |
Christoph J. Pfeiffer |
MRI-related artifacts after implantation of passive titanium implants and their influence on the detectability of cholesteatoma |
16:15 – 17:00 CET |
| PP3.06 |
Ingo Todt |
First clinical experience with a new device for the removal of cochlear schwannoma |
16:15 – 17:00 CET |
| PP3.07 |
Thijs Van Hees |
High-quality educational surgery videos |
16:15 – 17:00 CET |
| PP3.08 |
Ali Eftekharian |
CSF gusher in cochlear implantation; our experience with 30 cases |
16:15 – 17:00 CET |
| PP3.09 |
Thadé Goderie |
Treatment response evaluation in necrotizing otitis externa using FDG-PET imaging |
16:15 – 17:00 CET |
| PP3.10 |
Simon Kasper |
Treatment of sinus thrombosis secondary to mastoiditis. |
16:15 – 17:00 CET |
| PP3.11 |
Olaf Neve |
Automated measurement of vestibular schwannoma on MRI |
16:15 – 17:00 CET |
| PP3.12 |
Kimberley S Koetsier |
The course of hearing loss in patients with a progressive vestibular schwannoma |
16:15 – 17:00 CET |
